XML 81 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Balance Sheet Details (Tables)
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets as of December 31, 2024 and 2023 consisted of the following:
December 31,
20242023
(in thousands)
Interest receivable$20,262 $3,598 
Prepaid expenses15,732 6,159 
Deposits for equipment purchases
327 3,856 
Other current assets4,456 2,114 
Total$40,777 $15,727 
Schedule of Property and Equipment, Net
Property and equipment, net as of December 31, 2024 and 2023 consisted of the following:
December 31,
20242023
(in thousands)
Manufacturing facility build-out and equipment construction-in-progress
$151,785 $51,815 
Lab and manufacturing equipment55,541 33,244 
Furniture and equipment1,608 1,608 
Computers, computer software and office equipment1,001 771 
Leasehold improvements4,384 1,460 
Total property and equipment214,319 88,898 
Less: accumulated depreciation and amortization(16,274)(9,272)
Property and equipment, net$198,045 $79,626 
Summary of Other Assets
Other assets as of December 31, 2024 and 2023 consisted of the following:
December 31,
20242023
(in thousands)
Manufacturing facility construction buildout
$62,477 $34,688 
Other long-term assets1,882 2,874 
Total$64,359 $37,562 
Schedule of Accrued Expenses
Accrued expenses as of December 31, 2024 and 2023 consisted of the following:
December 31,
20242023
(in thousands)
Clinical studies$2,348 $2,156 
Other research and development24,698 30,759 
Acquired manufacturing rights (Note 7)
— 25,000 
Other accrued expenses2,077 1,900 
Total$29,123 $59,815